<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-MDG-T-CRS</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Contribute to the reduction of tuberculosis-related morbidity and mortality in Madagascar, according to the End TB strategy and Sustainable Development Goals</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Madagascar - Tuberculosis - Catholic Relief Services - United States Conference of Catholic Bishops - CRS HQ.  This program has the following goals: R&#xE9;duire le taux d&apos;incidence de la tuberculose de 50 % &#xE0; l&#x2019;horizon 2025 par rapport &#xE0; l&#x2019;ann&#xE9;e 2018/Reducing the incidence rate of tuberculosis by 50% by 2025 compared to 2018.  R&#xE9;duire le taux de mortalit&#xE9; due &#xE0; la tuberculose de 75% &#xE0; l&apos;horizon 2025 par rapport &#xE0; l&apos;ann&#xE9;e 2018/Reducing the mortality rate due to tuberculosis by 75% by 2025 compared to 2018. The objectives of this program are: Accro&#xEE;tre la couverture de traitement des nouveaux cas et rechutes en passant de 55% en 2018 &#xE0; 90% en 2024/Increasing treatment coverage for new cases and relapses from 55% in 2018 to 90% in 2024.  Traiter 100% des patients TB diagnostiqu&#xE9;s et accro&#xEE;tre le taux de succ&#xE8;s th&#xE9;rapeutique &#xE0; au moins 90% pour la TB sensible d&apos;ici 2024/Treating 100% of diagnosed TB patients and increasing the therapeutic success rate to at least 90% for susceptible TB by 2024.  Traiter 100% des patients TB-RR/MR diagnostiqu&#xE9;s et accro&#xEE;tre le taux de succ&#xE8;s th&#xE9;rapeutique &#xE0; au moins 75% pour la TB-MR jusqu&#x2019;en 2024/Treating 100% of diagnosed RR-MDR / MDR patients and increasing the therapeutic success rate to at least 75% for MDR-TB until 2024.  Assurer la pr&#xE9;vention &#xE0; au moins 90% des enfants contacts et des PvVIH apr&#xE8;s exclusion de la TB maladie d&#x2019;ici 2024/Ensuring prevention for at least 90% of contact children and PLHIV after exclusion of TB disease by 2024.  Assurer le d&#xE9;pistage VIH et la prise en charge ARV &#xE0; 100% des patients TB notifi&#xE9;s &#xE0; partir de 2021/Ensuring HIV testing and ARV care for 100% of TB patients notified from 2021.  Assurer une meilleure gestion du Programme &#xE0; tous les niveaux (suivi et &#xE9;valuation, collecte et exploitation des donn&#xE9;es pour la planification)/Ensuring better management of the Program at all levels (monitoring and evaluation, collection and use of data for planning)</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Madagascar</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Madagascar</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="8414ece0-6a4f-413f-a574-8bce599cbcf9" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="MDG-T-CRS" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-08-20" type="1"></activity-date>
  <activity-date iso-date="2020-08-20" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Youssouf SAWADOGO</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>youssouf.sawadogo@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Youssouf SAWADOGO</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>youssouf.sawadogo@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="MG" percentage="100">
   <narrative xml:lang="EN">Madagascar</narrative>
  </recipient-country>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="0.34" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="5.08" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="4.43" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="10.05" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="D8A4C47C-BD32-4DDC-98CD-FDAE0FD2B520" percentage="28.84" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Pharmaceutical Products (HPPP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="11.64" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="8.65" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="FDEDB289-7073-424F-8780-856D2FB8F704" percentage="0.42" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Infrastructure (INF)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="3.58" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="3.13" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="10.97" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="12.87" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1621809</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">2425932</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">1418524</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">907727</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1066917</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">1873229</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">911493</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">332938</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2021-01-01">1108540</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2021-01-01">2027186</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2021-01-01">938123</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2021-01-01">461860</value>
  </budget>
  <capital-spend percentage="4.43"></capital-spend>
  <transaction ref="3dc0963f-a168-4cc0-b275-13515fe09816">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-28"></transaction-date>
   <value currency="USD" value-date="2021-01-28">9264142.46</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MDG-T-CRS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4d6ba242-e521-462a-8a41-3979702bbafa">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-07-07"></transaction-date>
   <value currency="USD" value-date="2021-07-07">25000</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to MDG-T-CRS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e08aba14-2e6d-47c9-9b65-bf8fa9116684">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-05"></transaction-date>
   <value currency="USD" value-date="2021-02-05">1173391</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MDG-T-CRS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="b428b1e0-295e-4dd9-a171-83d0c2e5e2ce">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-19"></transaction-date>
   <value currency="USD" value-date="2021-02-19">1942231.46</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MDG-T-CRS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="885d142e-1caa-47d6-bebe-3213af68f482">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-05"></transaction-date>
   <value currency="USD" value-date="2021-08-05">180122.29</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MDG-T-CRS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="154a1717-a5db-4d68-bbbd-7a7ead16a167">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-08"></transaction-date>
   <value currency="USD" value-date="2021-09-08">688709.05</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MDG-T-CRS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="11c4bfd0-059d-47e5-b862-bd4a32b97c19">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-04"></transaction-date>
   <value currency="USD" value-date="2021-11-04">672210</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to MDG-T-CRS.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Catholic Relief Services - United States Conference of Catholic Bishops</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for MDG-T-CRS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
    </title>
    <baseline year="2019">
     <dimension name="TB regimen" value="New TB drugs"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB regimen" value="New TB drugs"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 26</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 26</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 49</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 49</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB regimen" value="Short regimens"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 50</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB regimen" value="Short regimens"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 50</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 50</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 50</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 165 Denominator: 217 Percentage: 76.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; community referrals</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 1923</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 1923</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 226 Denominator: 309 Percentage: 73.14</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 226 Denominator: 309 Percentage: 73.14</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of health facilities with tracer medicines for the three diseases available on the day of the visit or day of reporting</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 233 Denominator: 233 Percentage: 100.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 12013</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 12013</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 14323</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 14323</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 22503</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 22503</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24245</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24245</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24504</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 24504</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3046</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3046</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 309</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 309</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 33780</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 33780</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 36826</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 36826</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 24813 Denominator: 36826 Percentage: 67.38</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 24813 Denominator: 36826 Percentage: 67.38</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 27084 Denominator: 32522 Percentage: 83.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 27084 Denominator: 32522 Percentage: 83.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 456 Denominator: 912 Percentage: 50.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 456 Denominator: 912 Percentage: 50.00</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Type of report" value="TB reports"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 456 Denominator: 932 Percentage: 48.93</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Type of report" value="TB reports"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 456 Denominator: 932 Percentage: 48.93</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of people in contact with TB patients who began preventive therapy</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 5884</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 5884</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 870 Denominator: 36826 Percentage: 2.36</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 870 Denominator: 36826 Percentage: 2.36</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2018">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 0</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 25 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 25 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="TB case definition" value="XDR TB"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 25 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="TB case definition" value="XDR TB"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 25 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 12 Denominator: 13 Percentage: 92.31</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 12 Denominator: 13 Percentage: 92.31</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 21 Denominator: 21 Percentage: 100.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 21 Denominator: 21 Percentage: 100.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 21 Denominator: 25 Percentage: 84.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 21 Denominator: 25 Percentage: 84.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9 Denominator: 12 Percentage: 75.00</narrative>
     </comment>
    </baseline>
    <baseline year="2018">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9 Denominator: 12 Percentage: 75.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
    </title>
    <baseline year="2019">
     <dimension name="Type of report" value="TB reports"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 912 Denominator: 932 Percentage: 97.85</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <dimension name="Type of report" value="TB reports"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 912 Denominator: 932 Percentage: 97.85</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 912 Denominator: 932 Percentage: 97.85</narrative>
     </comment>
    </baseline>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 912 Denominator: 932 Percentage: 97.85</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for MDG-T-CRS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 233</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 199</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 179</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 161</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 179</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 161</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 48</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 45.17722</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 38</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 38</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for MDG-T-CRS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 139</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 131</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 134</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 137</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 134</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 137</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 21 Denominator: 25 Percentage: 84.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 42 Denominator: 50 Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 73.92 Denominator: 88 Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 84.15 Denominator: 99 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 73.92 Denominator: 88 Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 84.15 Denominator: 99 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 27084 Denominator: 32522 Percentage: 83.28</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 29974.56 Denominator: 35684 Percentage: 84.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 31740.02 Denominator: 36907 Percentage: 86.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 34993.8 Denominator: 38882 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 31740.02 Denominator: 36907 Percentage: 86.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 34993.8 Denominator: 38882 Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB treatment coverage: Percentage of new and relapse cases that were notified and treated among the estimated number of incident TB cases in the same year (all form of TB - bacteriologically confirmed plus clinically diagnosed)</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 36826 Denominator: 61636 Percentage: 59.75</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 36907 Denominator: 55919 Percentage: 66.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 38882 Denominator: 51842 Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 40853 Denominator: 48062 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 38882 Denominator: 51842 Percentage: 75.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 40853 Denominator: 48062 Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Notification of RR-TB and/or MDR-TB cases &#x2013; Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 78 Denominator: 430 Percentage: 18.14</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 99 Denominator: 394 Percentage: 25.13</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2021-07-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 110 Denominator: 365 Percentage: 30.14</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-06-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 135 Denominator: 339 Percentage: 39.82</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-07-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 110 Denominator: 365 Percentage: 30.14</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-07-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 135 Denominator: 339 Percentage: 39.82</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
